Last update 01 Nov 2024
Sinomab Bioscience Ltd.

Sinomab Bioscience Ltd.

Public Company|
2001|
Hong Kong SAR, China
|
250-500
| HKG: 3681|

Overview

Basic Info

Introduction
SinoMab Bioscience is a clinical-stage biopharmaceutical firm that specializes in creating, developing, and manufacturing therapeutics for immunological diseases, with a focus on monoclonal antibody-based biologics. The company was established by Shui On Leung on April 27, 2001 and is located in Hong Kong.

Tags

Immune System Diseases
Skin and Musculoskeletal Diseases
Hemic and Lymphatic Diseases
Monoclonal antibody
Antibody
Small molecule drug

Disease domain score
A glimpse into the focused therapeutic areas
Technology Platform
Most used technologies in drug development
Targets
Most frequently developed targets
Top 5 Drug TypeCount
Antibody4
Monoclonal antibody4
Small molecule drug1
Biosimilar1

Corporation Tree

Boost your research with our corporation tree data.
Boost your research with our corporation tree data.

Pipeline

Pipeline Snapshot as of 07 Nov 2024

The statistics for drugs in the Pipeline is the current organization and its subsidiaries are counted as organizations,Early Phase 1 is incorporated into Phase 1, Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3
Preclinical
6
1
Phase 1 Clinical
Phase 2 Clinical
1
1
NDA/BLA
Other
3
Login to view more data

Current Projects

Drug(Targets)IndicationsGlobal Highest Phase
Suciraslimab
( CD22 )
Rheumatoid Arthritis
More
NDA/BLA
Civorebrutinib
( BTK )
Pemphigus
More
Phase 2
SM-17
( IL17RB )
Dermatitis, Atopic
More
Phase 1
SM09
( CD20 )
Rheumatoid Arthritis
More
Preclinical
SM-22
Immune System Diseases
More
Preclinical
Login to view more data

Deal

Boost your decision using our deal data.
Boost your decision using our deal data.

Translational Medicine

Boost your research with our translational medicine data.
Boost your research with our translational medicine data.

Profit

Explore the financial positions of over 360K organizations with Synapse.
Explore the financial positions of over 360K organizations with Synapse.

Grant & Funding(NIH)

Access more than 2 million grant and funding information to elevate your research journey.
Access more than 2 million grant and funding information to elevate your research journey.

Investment

Gain insights on the latest company investments from start-ups to established corporations.
Gain insights on the latest company investments from start-ups to established corporations.

Financing

Unearth financing trends to validate and advance investment opportunities.
Unearth financing trends to validate and advance investment opportunities.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free